Regions Financial Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,539
Closed -$396K 887
2020
Q4
$396K Sell
2,539
-230
-8% -$29.6K ﹤0.01% 612
2020
Q3
$317K Buy
2,769
+296
+12% +$31.9K ﹤0.01% 628
2020
Q2
$277K Sell
2,473
-6
-0.2% -$637 ﹤0.01% 655
2020
Q1
$223K Buy
2,479
+45
+2% +$4.42K ﹤0.01% 683
2019
Q4
$263K Sell
2,434
-152
-6% -$16.3K ﹤0.01% 713
2019
Q3
$253K Buy
2,586
+2
+0.1% +$225 ﹤0.01% 701
2019
Q2
$339K Sell
2,584
-116
-4% -$15K ﹤0.01% 616
2019
Q1
$364K Sell
2,700
-110
-4% -$13.7K ﹤0.01% 604
2018
Q4
$273K Sell
2,810
-148
-5% -$17.5K ﹤0.01% 668
2018
Q3
$412K Buy
2,958
+353
+14% +$44.3K ﹤0.01% 614
2018
Q2
$323K Buy
2,605
+107
+4% +$12.5K ﹤0.01% 685
2018
Q1
$278K Sell
2,498
-137
-5% -$16.4K ﹤0.01% 736
2017
Q4
$316K Buy
2,635
+125
+5% +$15.2K ﹤0.01% 723
2017
Q3
$352K Sell
2,510
-1,138
-31% -$155K ﹤0.01% 712
2017
Q2
$444K Sell
3,648
-18,933
-84% -$2.2M 0.01% 673
2017
Q1
$2.74M Sell
22,581
-7,461
-25% -$962K 0.03% 233
2016
Q4
$3.68M Buy
30,042
+1,767
+6% +$216K 0.05% 198
2016
Q3
$3.46M Buy
28,275
+7,894
+39% +$1.02M 0.04% 202
2016
Q2
$2.38M Sell
20,381
-27
-0.1% -$3.83K 0.03% 244
2016
Q1
$2.84M Buy
20,408
+171
+0.8% +$25.1K 0.04% 221
2015
Q4
$3.86M Buy
20,237
+837
+4% +$146K 0.05% 202
2015
Q3
$3.03M Buy
19,400
+5,241
+37% +$956K 0.04% 213
2015
Q2
$2.56M Buy
14,159
+8,512
+151% +$1.47M 0.03% 259
2015
Q1
$979K Buy
5,647
+3
+0.1% +$543 0.01% 516
2014
Q4
$1.04M Sell
5,644
-14,693
-72% -$2.72M 0.01% 504
2014
Q3
$3.37M Sell
20,337
-1,726
-8% -$283K 0.04% 236
2014
Q2
$3.45M Buy
22,063
+2,322
+12% +$367K 0.04% 241
2014
Q1
$3M Sell
19,741
-6,803
-26% -$1.08M 0.04% 263
2013
Q4
$3.53M Sell
26,544
-885
-3% -$106K 0.04% 236
2013
Q3
$3.19M Sell
27,429
-5,498
-17% -$603K 0.04% 240
2013
Q2
$3.04M Buy
+32,927
New +$3.17M 0.04% 226

Other funds holding ALXN